BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Drug Development

  InterMune, Inc. to Present Abstracts on HCV Protease Inhibitor ITMN-191 and HCV Development Program at the EASL Meeting

  March 18, 2009

   · 

  3 min read
• Business

  RXi Pharmaceuticals Reports Fourth Quarter and 2008 Financial Results

  March 18, 2009

   · 

  1 min read
• Drug Development

  Novogen Limited’s NV-128 Targets the mTOR Pathway to Induce Cell Death in Epithelial Ovarian Cancer Stem Cells

  March 18, 2009

   · 

  5 min read
• BioMidwest

  Vertex Pharmaceuticals Incorporated Announces Acceptance of Telaprevir and VCH-222 Abstracts for Presentation at EASL Annual Meeting

  March 18, 2009

   · 

  1 min read
• Drug Development

  Chelsea Therapeutics, Inc. Reports Positive Results From Phase II Trial of CH-1504 in Rheumatoid Arthritis

  March 18, 2009

   · 

  1 min read
• Business

  Hana Biosciences, Inc. to Report Fourth Quarter and Full Year 2008 Financial Results On March 31, 2009

  March 18, 2009

   · 

  1 min read
• Policy

  Warner Chilcott Denied Stay on 2 Doryx Doses

  March 18, 2009

   · 

  4 min read
• Drug Development

  BioDelivery Sciences International Release: BEMA Buprenorphine to Proceed to Phase 2 Following Favorable Initial Study Results

  March 18, 2009

   · 

  1 min read
• Biovail Corporation Announces Annual and Special Meeting of Shareholders

  March 18, 2009

   · 

  1 min read
• Business

  Covidien Ltd Declares Quarterly Cash Dividend

  March 18, 2009

   · 

  1 min read